Positive results have been reported from a phase II trial comparing it with amoxicillin. Another phase II trial began in 2010 comparing it with linezolid for treatment of acute bacterial skin and skin structure infections (ABSSSI). No development activity has been reported since 2015.
Linopristin/flopristin
Isoniazid/pyridoxine/sulfamethoxazole/trimethoprim
Isoniazid/rifampicin
Benzathine benzylpenicillin
Rifampicin/isoniazid/pyrazinamide
Ethambutol/isoniazid/rifampicin
Rifabutin
Atazanavir/cobicistat